Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.29
0.0000
Volume:- -
Turnover:- -
Market Cap:64.44M
PE:-1.34
High:1.29
Open:1.29
Low:1.29
Close:1.29
52wk High:3.42
52wk Low:0.9310
Shares:49.95M
Float Shares:12.61M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9595
EPS(LYR):-1.1203
ROE:-354.27%
ROA:-17.49%
PB:-10.94
PE(LYR):-1.15

Loading ...

Quanterix Q2 revenue falls 29%, net loss widens

Reuters
·
Aug 08

Quanterix Reports Q2 Net Loss of $30M, Alzheimer's Diagnostics Revenues More Than Tripled Year-Over-Year

Reuters
·
Aug 08

Quanterix Corporation Announces Workforce Reduction Plan to Save $18 Million Annually Following Akoya Biosciences Acquisition

Reuters
·
Jul 25

Quanterix Corporation Announces Executive Terminations at Akoya Biosciences in Cost-Saving Reorganization Plan

Reuters
·
Jul 19

Quanterix Corporation Announces Inducement Grants of Restricted Stock Units to New Employees Following Akoya Biosciences Acquisition

Reuters
·
Jul 12

Quanterix Corporation Announces New Board Members as Mendel and Lai-Goldman Join Leadership Team Following Akoya Acquisition

Reuters
·
Jul 08

Akoya Biosciences Inc. Conducted Special Stockholders Meeting

Reuters
·
Jul 08

Akoya Biosciences Receives Unsolicited Acquisition Proposal Amid Merger Talks with Quanterix

Reuters
·
Jun 03

Akoya Shares Gain on Unsolicited Third-Party Acquisition Proposal

Dow Jones
·
May 22

Sector Update: Health Care Stocks Slide Wednesday Afternoon

MT Newswires Live
·
May 22

Akoya Biosciences Receives Unsolicited Buyout Offer From Third Party

MT Newswires Live
·
May 21

BRIEF-Akoya Biosciences Inc - On May 20, Receives Unsolicited Acquisition Proposal At $1.40 Per Share From A Third Party- SEC Filing

Reuters
·
May 21

Akoya Biosciences Receives Unsolicited Acquisition Proposal Amid Ongoing Merger Discussions with Quanterix

Reuters
·
May 21

Akoya Biosciences Is Maintained at Hold by Canaccord Genuity

Dow Jones
·
May 19